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A simple and versatile method for the synthesis of 1,5-benzodiazepines is via condensation of o-phenylenediamines (OPDA) and
ketones in the presence of catalytic amount of H-MCM-22 using acetonitrile as solvent at room temperature. In all the cases, the
reactions are highly selective and are completed within 1–3h. The method is applicable to both cyclic and acyclic ketones without
signiﬁcant diﬀerences. The reaction proceeds eﬃciently under ambient conditions with good-to-excellent yields.
1.Introduction
Benzodiazepinesconstituteanimportantclassofbiologically
active compounds and their synthesis has been receiving
much attention in the ﬁeld of medicinal and pharmaceutical
chemistry owing to their application as anticonvulsant, anti-
inﬂammatory, analgesic, hypnotic, and sedative agents and
to their hypnotic activity [1–6]. The derivatives of 1,5-
benzodiazepines are also used as dyes for acrylic ﬁbers in
photography [7]. In addition, benzodiazepines are the useful
precursors for the synthesis of other fused ring compounds
such as triazolo-, oxadiazolo-, oxazino-, or furano-benzo-
diazepines [8–11]. Benzodiazepines are generally synthe-
sized by the condensation of o-phenylenediamine (OPDA)
with a,b-unsaturated carbonyl compounds, b-haloketones,
or with ketones [12] using acidic catalysts which are critical
to enhance the condensation process. Diﬀerent reagents such
as BF3-etherate, polyphosphoric acid, NaBH4,M g O / P O C l 3,
Yb(OTf)3,G a ( O T f ) 3, lead nitrate, L-proline, acetic acid
under microwave conditions, molecular iodine, and ionic
liquids have also been used for the synthesis of benzodi-
azepines [13–23]. Recently the synthesis of benzodiazepines
has also been reported using diﬀerent solid acid catalysts
such as sulfated zirconia, Al2O3/P2O5,A g 3PW12O40,P V P -
FeCl3, and zeolite catalysts [24–28]. Unfortunately, many
of these catalysts suﬀer from one or more limitations,
such as long reaction times, occurrence of several side
reactions,drastic reactionconditions, low yields,andtedious
workup procedure. In addition, the solid oxide catalyst
used previously had poor textural parameters such as low
surface area and pore volume which do not support a better
performance in the synthesis of benzodiazepines. These
factorsstimulatethesearchforabettercatalyst,whichshould
oﬀer a high activity for the synthesis of 1,5-benzodiazepines
under mild reaction conditions. In recent years, mesoporous
materialswithdiﬀerentstructureandtunableporediameters
have been receiving much attention.
Here we demonstrate, the synthesis of 1,5-benzodiaze-
pine using H-MCM-22 as catalyst through a condensation
reaction between OPDA and ketones in acetonitrile condi-
tion. The eﬀect of catalyst and the catalyst concentration on
the above process has been investigated in detail.
2.ExperimentalSection
2.1. Synthesis of Catalysts Synthesis of (H-MCM-22). The
hydrothermal synthesis of layered aluminosilicate MCM-
22 was carried out by using hexamethyleneimine as an
organic template at dynamic conditions. A total of 3.110g
of anhydrous sodium aluminate (50–56% Al2O3,m a x i -
mum 0.05% Fe2O3, 40–45% Na2O, purchased from Riedel-
deHa¨ en) and 1.930g of sodium hydroxide (97%, from
Merck) was dissolved in 415g of deionized water. The2 Journal of Biomedicine and Biotechnology
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Scheme 1: Synthesis of 1,5-benzodiazepines using H-MCM-22 catalysts at room temperature.
solution was thoroughly stirred for 15 minutes, and then
25.4g of hexamethyleneimine (HMI) (99%, from Aldrich)
was added dropwise with vigorous stirring. To this, 30.7g
of silica (Aerosil 200, Degussa) was added in small portions
and the resulting slurry continued to be stirred vigorously.
After 30 minutes of stirring, at room temperature, a gel was
formed; this was then placed in an autoclave and heated at
150◦C for 10 days. After immersing the autoclaves in cold
water, the resulting material was washed and centrifuged
until pH ≤ 9 and subsequently dried at 70◦C. A 1-gram
sample of MCM-22 was calcined in the absence of air at
650◦C for 7 hours, generating Na-MCM-22 zeolite. The
process took place in an oven in order to remove water and
organic precursor. The oven was programmed at a heating
rateof5◦C/min until 650◦C for 7h. The Na-MCM-22 zeolite
is converted into the H-form by the following procedure:
9.000g of Na-MCM-22, 7.230g of NH4Cl, and 13.80mL of
deionized water were mixed with 0.1M hydrochloric acid
solution, in order to reach pH 4.0. The mixture was stirred
at 60◦C for 30min. Then the material was ﬁltered under
suction and washed with deionized water. After the removal
of chlorides, the resulting material, NH4-MCM-22 zeolite,
wasplac edinano v e nat60 ◦C for24h. Theammoniumform
of MCM-22 was converted into H-form by calcination over
60min at 200◦C.
2.2. Characterization of the Catalysts and the Products. X-
Ray Diﬀraction (XRD): the samples were sieved in an
ABNT n◦ 200 (0.074mm) sieve and then placed in an
aluminum sample holder for X-ray diﬀraction assays, using
a Shimadzu XRD 6000 equipment. The operational details
of the technique were set as follows: copper Kα radiation at
40KV/30mA, with a goniometer speed of 2◦/min and a step
of 0.02◦ in the 2θ range scanning from 2◦ to 50◦.T h eo n l y
d-spacings of interest in the X-ray patterns were the basal
spacings along the c axis.
Fourier-transform infrared (FT-IR) spectroscopy: the
MCM-22 sample was submitted to physical treatment in
accordance with the KBr method, which consists of mixing
0.007g of the sample and 0.1g of KBr, grinding and pressing
the solid mixture to 5 ton for 30s in order to form a pastille
that allows the passage of light. Characterization was per-
formed using an infrared spectrophotometer SHIMADZU
FT-IR in the wavelength ranges from 2000 to 400cm−1,w i t h
increments of 650cm−1 and a resolution of 4cm−1.
Characterization of the product was performed on
SHIMADZU FT-IR spectrometer, and the sample was pre-
pared with KBr and pressed into wafer/pellet. Spectra were
collected in the range of 400–4000cm−1. NMR of the
products was performed on BRUKER ADVANCE II 300
NMR spectrometer.
Gas chromatography for benzodiazepine was performed
using Younglin gas chromatograph (YL6100 GC). A narrow-
bore capillary column (25m × 0.22 with 0.25μm thickness)
was used and an oven temperature of 250◦Cw a se m p l o y e d
with injector and detector temperature of 2750C. Yield was
calculated from the peak area
Area = Height of peak × Width at half-height, (1)
and % yield was calculated as
%y i e l d=
Area of component
Total area
×100. (2)
2.3. Synthesis of 1,5-Benzodiazepine. A mixture of OPDA
(1mmol, 108.1mg), ketone (2.5mmol, 145.2mg), and H-
MCM-22 (100mg) was stirred in acetonitrile (4mL) at
roomtemperatureuntilthinlayerchromatographyindicated
the reaction was completed (as shown in Scheme 1). Ethyl
acetate (10%) in hexane was used as the mobile phase
and both the reactant and the ﬁnal product were spotted
on the TLC plate. The product retention factor (Rf) was
observed at 0.4. The disappearance of the reactant spot on
the TLC place indicates the completion of the reaction. After
completion of the reaction, ethyl acetate (20mL) was added
to the reaction mixture and the catalyst was recovered by
ﬁltration. The organic layer was concentrated and the crude
product was puriﬁed by silica gel column chromatography
using ethyl acetate: n-hexane (1:9) as eluent to aﬀord the
desired product.
Entry 1 (2a). Yellow solid; m.p. 137–139◦C FT-IR (KBr):
υmax (in Cm−1) 3362, 1501, 1474; 1H NMR (300MHz,
CDCl3): δ(ppm): 7–7.25 (m, 4H, Ar-H), 2.90–2.95 (d, 1H,
CH),3.90–4.25(m,2H,CH2),3.5(brs,1H,NH),3(s,2H,N
=C-CH2),2.5(m,3H,N=C-CH3),1.50–1.75(s,6H,2CH3).
E n t r y2( 2 b ) .Yellow solid; m.p. 137–139◦C; FT-IR (KBr):
υmax (in Cm−1) 3329, 1637,1605; 1H NMR (300MHz,
CDCl3): δ (ppm): 0.99 (t, 3H, J = 6.9Hz), 1.25 (t, 3H, J =
6.9Hz), 1.70 (q, 2H, J = 6.9Hz) 2.15 (m, 2H), 2.35 (s, 3H),
2.69 (q, 2H, J = 6.9Hz), 3.25 (br s, 1H, NH), 6.78–7.35 (m,
4H); 13C NMR (50MHz, CDCl3) δ(ppm): 8.7, 10.6, 26.9,
35.5, 35.7, 42.0, 70.7, 121.7, 125.2, 126.2, 27.1, 138.0, 140.9,
175.5.
Entry 3 (2c). Yellow solid; m.p. 151–152◦C; FT-IR (KBr):
υmax (in Cm−1) 3330, 1635; 1H NMR (300MHz, CDCl3): δ
(ppm): 1.80(s, 3H), 2.95 (d, 1H, J = 12.8Hz), 3.15 (d, 1H,
J = 12.8Hz) 3.45 (br s, NH), 6.55–7.0 (m, 3H), 7.15–7.35
(m, 7H), 7.55–7.65 (m, 4H); 13C NMR (50MHz, CDCl3)
δ(ppm):167.5,146.6,140.1,139.5,138.2,129.8,128.6,128.4,Journal of Biomedicine and Biotechnology 3
128.1, 127.4, 127.1, 126.4, 125.5, 121.7, 121.5, 73.9, 43.0,
29.9.
Entry 4 (2d). Yellow solid; m.p 164–165◦C, FT-IR (KBr):
υmax (in Cm−1): 3375; 1H NMR (300MHz, CDCl3): δ
(ppm): 1.48–1.84 (m, 10H), 4.15 (br s, 1H, NH), 4.69
(br s, 1H, NH), 6.37 (d, 2H), 7.71 (d,d, 2H). 13C NMR
(50MHz, CDCl3): d = 23.50, 25.04, 39.83, 82.15, 103.35,
104.84, 119.80, 132.35, 140.62, 146.20.
Entry 5 (2e). Yellow solid; m.p. 156–158◦C, FT-IR (KBr):
υmax (in Cm−1): 3344, 1647, 1603. 1H NMR (300MHz,
CDCl3): δ (ppm): 1.88–2.10 (m, 12H, 6CH2), 2.90–2.95 (d,
1H,CH),3.90–4.25(m,2H,CH2),3.05(brs,1H,NH),6.63–
6.64 (m, 1H, Ar-H), 6.73–6.77 (m, 1H, Ar-H), 7.87–7.90 (m,
1H, Ar-H).
E n t r y6( 2 f ) .Yellow solid, m.p. 94–96◦C, IR(KBr): mmax
3424, 1595, 1499cm−1. 1H NMR (300MHz, CDCl3): d 0.93
(t, 3H, CH3), 1.24–1.25 (m, 6H, 2CH3), 1.60–1.65 (m, 2H,
CH2), 2.22 (m, 2H, CH2), 2.50–2.68 (q, 2H, J = 3.23Hz,
CH2), 3.00–3.20 (br s, 1H, NH), 6.62–6.71 (m, 1H, Ar-H),
6.88–6.93 (m, 1H, Ar-H), 7.04–7.14 (m, 1H, Ar-H).
Entry 7 (2g). Pale yellow solid, m.p. 138–140◦C, IR(KBr):
mmax 3320, 1602, 1567cm−1. 1H NMR (300MHz, CDCl3):
d 1.72 (s, 3H, CH3), 2.17 (s, 2H, CH2), 2.33 (s, 6H, 2CH3)
3.00 (br s, 1H, NH), 6.80–6.81 (m, 1H, Ar-H), 7.06–7.10 (m,
5H, Ar-H), 7.42–7.53 (m, 5H, Ar-H).
Entry8(2h). Yellowsolid;m.p.135-136◦CFT-IR(KBr):υmax
(in Cm−1) 3352, 1501, 1474; 1H NMR (300MHz, CDCl3):
δ(ppm):7–7.25(m,4H,Ar-H),2.90–2.95(d,1H,CH),3.90–
4.25 (m, 2H, CH2), 3.5 (br s, 1H, NH), 3 (s, 2H, N=C-CH2),
2.5 (m, 3H, N=C-CH3), 1.50–1.75 (s, 6H, 2CH3).
3. Result andDiscussion
The XRD patterns of samples of MCM-22 zeolite are in
agreement with those already reported [30–32]. All acquired
X-ray patterns identiﬁed the products as highly crystalline
materials.
The FTIR spectrum of MCM-22 shows the presence of
bands related to the symmetrical and asymmetrical stretch-
ing of O-H band. The band at 786cm−1 refers to external
symmetrical stretching, whilst the band at 1237cm−1 refers
to external asymmetric stretching. The bands at 1095 and
1070cm−1 correspond to internal asymmetric stretching and
the bands at 594 and 550cm−1 are attributed to the presence
of double rings in MCM-22 structure. At 1626cm−1 the
band is ascribed to the angular deformation of the N–H
bond and water. The band at 449cm−1 is related to the
internal deformation of O–H bands [33]. The band centered
at 1384cm−1 indicates the presence of amine functional
group (HMI).
Initially the focus was on the synthesis of 1,5-benzo-
diazepine. The reaction was carried out using H-MCM-22
through a simple condensation reaction between OPDA and
Table 1: Eﬀect of weight of H-MCM-22 on the synthesis of 1,5-
benzodiazepine.
Weight of catalyst Reaction time Yield
mg Min. %
50 60 30
100 60 50
150 60 87
200 60 88
Reaction conditions: Substrate: OPDA and acetone, reaction temperature:
RT, solvent: acetonitrile.
acetone using acetonitrile as solvent at room temperature
and the results are given in Table 2. The catalyst was found
to be highly active, aﬀording 87% isolated yield of 1,5-
benzodiazepine in 60min. It should also be noted that when
the reaction wasconductedwithout any catalyst,the reaction
does not occur. These results indicate that the acidity of
the catalyst plays a critical role in this transformation and
dictates the activity of the catalyst. The role of Br¨ onsted
acid site of H-MCM-22 catalyst on the formation of 1,5-
benzodiazepine and the reaction mechanism are clearly
depicted in Scheme 2. As H-MCM-22 showed a much higher
activity than other catalysts used in this study under the
optimized reaction conditions, we have used H-MCM-22 for
the remaining catalytic studies.
Thesynthesisof1,5-benzodiazepineswasalsocarriedout
over diﬀerent amounts of H-MCM-22 at room temperature
for 60min and the results are given in Table 1. The weight of
catalyst was increased between 50 and 200mg. It was found
that the yield increases from 30% to 87% with increase in the
weight of the catalyst from 50 to 150mg, respectively. This
could be mainly due to the availability of huge number of
acidic sites on the porous surface of H-MCM-22. It should
be noted that the yield of the product remains constant with
the further increase in the weight of the catalyst from 150 to
200mg. Hence, we used the weight of the catalyst as 150mg
for rest of the studies.
The excellent catalytic performance of H-MCM-22 in
the synthesis of 1,5-benzodiazepine stimulated us to extend
this process for the synthesis of various derivatives of
benzodiazepines using various substituted OPDAs and a
series of symmetrical and unsymmetrical ketones and the
results are shown in Table 2. In all the cases, the reactions
are highly selective and are completed within 1–3h. The
catalyst showed excellent activity in all the cases, showing
65–87% isolated yield of the corresponding derivatives of
1,5-benzodiazepine. It was found that the catalyst showed
superior performance with high yields in a relatively shorter
reactiontimethanErsorb-4(E4),aclinoptylolite-typezeolite
catalyst reported earlier [28]. It was interesting to see that
E4 needed a high temperature and a longer reaction time
conditions to achieve high isolated yield of the ﬁnal product
whereas H-MCM-22 was active even at room temperature.
These ﬁndings reveal the superior nature of the studied
catalyst in this transformation.
Chlorosubstituted OPDA and substituted ketones were
also used with similar success to provide the corresponding4 Journal of Biomedicine and Biotechnology
Table 2: Synthesis of 1,5-benzodiazepines and its derivatives using H-MCM-22 through a condensation reaction between a series of OPDA
and various ketones.
Entry Diamine Ketone Product Time
(min) Yield (%)
1
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H2N
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N
N
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Scheme 2: Reaction mechanism of the synthesis of 1,5-benzodiazepines using H-MCM-22 catalyst at room temperature [29].
benzodiazepines in high yields, which are of much interest
with regard to biological activity. Chlorosubstituted benzo-
diazepines in good yields in the presence of this catalyst were
achieved easily.
It is also important to note that the workup of the reac-
tion mixture is very simple. The catalyst can be ﬁltered out
easily and the solvent was evaporated. Recycling experiments
were conducted to ﬁnd out the stability of the catalyst after
the reaction. The catalyst was easily separated by centrifuge
and reused after activation at 500◦C for 3-4h. The eﬃciency
of the recovered catalyst was veriﬁed with the reaction of
OPDA and Ketone (Entry 1). Using the fresh catalyst, the
yield of product (2a) was 87%, while the recovered catalyst
in the three subsequent recyclization gave the yields of 85%,
81%, and 75%, respectively. The small reduction in the
catalytic activity after three reaction cycles may be mainly
due to the loss of catalyst or catalyst structure during the
recovery process. These results reveal that the catalyst can be
recycled several times without much loss in its activity.
4. Conclusion
The work reported has used H-MCM-22 catalyst for the syn-
thesisofvariousbenzodiazepinesbyusingsubstitutedOPDA
and a series of symmetrical and unsymmetrical ketones at
roomtemperature.Thismethodisquitesimpleandselective.
The catalyst gave high isolated yield of the derivatives
of 1,5-benzodiazepine in a shorter reaction time at room
temperature and can be recycled several times. We strongly
hope that the highly stable H-MCM-22 catalyst could pave
the way for the production of 1,5-benzodiazepine and its
derivativesandcreatetheplatformforthecommercialization
of the process by replacing the existing homogenous catalysts
which suﬀered from various drawbacks such as corrosion,
toxicity, waste production, and high cost.
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